Insider Selling: Delek US (NYSE:DK) CEO Sells $2,054,000.00 in Stock

Delek US Holdings, Inc. (NYSE:DK) CEO Avigal Soreq sold 50,000 shares of Delek US stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $41.08, for a total transaction of $2,054,000.00. Following the transaction, the chief executive officer owned 251,678 shares in the company, valued at approximately $10,338,932.24. This trade represents a 16.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Delek US Trading Down 5.4%

Shares of DK stock opened at $42.35 on Friday. The company has a debt-to-equity ratio of 5.89, a quick ratio of 0.58 and a current ratio of 0.82. The stock has a fifty day simple moving average of $32.38 and a two-hundred day simple moving average of $33.38. The firm has a market capitalization of $2.54 billion, a PE ratio of -121.00 and a beta of 0.75. Delek US Holdings, Inc. has a 52-week low of $11.02 and a 52-week high of $45.74.

Delek US (NYSE:DK) last announced its quarterly earnings data on Friday, February 27th. The oil and gas company reported $0.44 EPS for the quarter, beating the consensus estimate of ($0.19) by $0.63. The business had revenue of $2.43 billion for the quarter, compared to the consensus estimate of $2.55 billion. Delek US had a negative return on equity of 13.55% and a negative net margin of 0.21%.The business’s revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the business earned ($2.54) earnings per share. On average, analysts predict that Delek US Holdings, Inc. will post -5.5 EPS for the current fiscal year.

Delek US Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 9th. Investors of record on Monday, March 2nd will be issued a $0.255 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $1.02 dividend on an annualized basis and a yield of 2.4%. Delek US’s payout ratio is currently -291.43%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of DK. ION Fund Management Ltd purchased a new position in shares of Delek US in the fourth quarter valued at $52,427,000. Norges Bank purchased a new stake in Delek US during the fourth quarter valued at $48,374,000. Arrowstreet Capital Limited Partnership raised its stake in Delek US by 6,300.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,306,269 shares of the oil and gas company’s stock valued at $42,153,000 after purchasing an additional 1,285,861 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Delek US by 1,516.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 996,059 shares of the oil and gas company’s stock valued at $29,544,000 after purchasing an additional 934,448 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Delek US by 1,173.2% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 954,900 shares of the oil and gas company’s stock worth $28,322,000 after buying an additional 879,900 shares in the last quarter. 97.01% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DK has been the topic of several recent analyst reports. Citigroup reduced their price objective on shares of Delek US from $37.00 to $33.00 and set a “neutral” rating on the stock in a research report on Monday, January 26th. Piper Sandler dropped their target price on shares of Delek US from $47.00 to $40.00 and set a “neutral” rating for the company in a research report on Thursday, January 8th. Morgan Stanley cut their target price on shares of Delek US from $40.00 to $38.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 27th. Wells Fargo & Company boosted their price target on shares of Delek US from $43.00 to $53.00 and gave the stock an “overweight” rating in a research note on Monday, November 10th. Finally, UBS Group increased their price objective on shares of Delek US from $31.00 to $42.00 and gave the company a “neutral” rating in a report on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Delek US presently has a consensus rating of “Hold” and an average price target of $39.46.

More Delek US News

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.